AMPH
AMPH
NASDAQ · Pharmaceuticals

Amphastar Pharmaceuticals In

$22.74
+0.86 (+3.93%)
As of May 9, 1:35 AM ET ·
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Buy 8 62%
Hold 5 38%
Sell 0 0%
Price Target
Analyst Price Target +184.7% upside
Low Target $41.78
Average Target $64.73
High Target $94.19
Current Price $22.74
Current
$22.74
Target
$64.73
$41.78 $64.73 avg $94.19
Scenario Analysis
Bear Case
$41.78
83.7%
Low target
Base Case
$64.73
+184.7%
Avg target
Bull Case
$94.19
+314.2%
High target
Risk/Reward
3.8x
Highly favorable
Price in Context
52-Week High
$31.26
-27.3% from high
52-Week Low
$17.03
+33.5% from low
Target vs 52W High
$64.73
+107.0% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $0.72
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%